|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Enflurane | CAS 13838-16-9 | ||
| CHF2OCF2CHClF | RTECS KN6800000 | ||
|
Synonyms & Trade Names 2-Chloro-1-(difluoromethoxy)-1,1,2-trifluoroethane; 2-Chloro-1,1,2-trifluoroethyl difluoromethyl ether; Ethrane® |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL*: C 2 ppm (15.1 mg/m3) [60-minute] [*Note: REL for exposure to waste anesthetic gas.] | ||
| OSHA PEL: none | |||
| IDLH N.D. | Conversion 1 ppm = 7.55 mg/m3 | ||
|
Physical Description Clear, colorless liquid with a mild, sweet odor. [inhalation anesthetic] |
|||
|
MW: 184.5 |
BP: 134°F |
FRZ: ? |
Sol: Low |
|
VP: 175 mmHg |
IP: ? |
|
Sp.Gr(77°F): 1.52 |
|
Fl.P: NA |
UEL: NA |
LEL: NA |
|
| Noncombustible Liquid | |||
|
Incompatibilities & Reactivities None reported |
|||
|
Measurement Methods OSHA 29, 103 |
|
Personal Protection & Sanitation Skin: No recommendation Eyes: Prevent eye contact Wash skin: No recommendation Remove: No recommendation Change: No recommendation |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash Breathing: Respiratory support Swallow: Medical attention immediately |
| Respirator Recommendations To be added later | |
| Exposure Routes inhalation, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes; central nervous system depression, analgesia, anesthesia, convulsions, respiratory depression | |
|
Target Organs
Eyes, central nervous system |
|
| See also: INTRODUCTION |